The multifactorial origin of growth failure in thalassaemia.

Keyphrases

• Anemia 25%
• Body Disproportion 25%
• Body Segment 25%
• Bone Disease 25%
• Bone Marrow Transplantation 25%
• Calcium Homeostasis 25%
• Chelating Agent 25%
• Children with Thalassemia 25%
• Chronic Anemia 25%
• Chronic Hypoxia 25%
• Chronic Liver Disease 25%
• Delayed Puberty 25%
• Desferrioxamine 25%
• Dysregulation 25%
• Emotional Factors 25%
• Endocrine Complications 25%
• Endocrine Glands 25%
• Endocrinopathy 25%
• Etiology 50%
• Folic Acid Deficiency 25%
• Free Iron 25%
• GH/IGF-1 Axis 50%
• Growth Delay 25%
• Growth Disturbance 50%
• Growth Failure 100%
• Growth Pattern 25%
• Growth Phase 25%
• Growth Retardation 50%
• Growth Spurt 25%
• Growth Velocity 25%
• Hemosiderosis 25%
• Hypogonadism 25%
• Hypothyroidism 25%
• Hypoxia 25%
• Induced Damage 25%
• Ineffective Erythropoiesis 25%
• Intensive Use 25%
• Iron Chelation Therapy 25%
• Iron Overload 25%
• Late childhood 25%
• Life Expectancy 25%
• Lower Body 25%
• Normal Growth 25%
• Nutritional Deficiency 25%
• Nutritional Factors 25%
• Phase Growth 50%
• Prolonged Life 25%
• Pubertal Growth Spurt 25%
• Puberty 25%
• Quality of Life 25%
• Slowing down 25%
• Social Adjustment 25%
• Social Quality 25%
• Thalassemia 100%
• Therapeutic Advances 25%
• Therapeutic Progress 25%
• Upper Body 25%
• Zinc 25%
• β-Thalassemia (β-thal) 100%

Medicine and Dentistry

• Adolescence 33%
• Anemia 33%
• Bone Disease 16%
• Bone Marrow Transplantation 16%
• Calcium Homeostasis 16%
• Chelating Agent 16%
• Chelation Therapy 16%
• Chronic Liver Disease 16%
• Deferoxamine 16%
• Delayed Puberty 16%
• Emotion 16%
• Endocrine Disease 16%
• Endocrine Gland 16%
• Folate Deficiency 16%
• Growth Acceleration 33%
• Growth Disorder 100%
• Growth Rate 16%
• Growth Retardation 33%
• Growth, Development and Aging 16%
• Hemosiderosis 16%
• Hypogonadism 16%
• Hypothyroidism 16%
• Hypoxia 33%
• Ineffective Erythropoiesis 16%
• Iron Overload 16%
• Life Expectancy 16%
• Nutritional Deficiency 16%
• Quality of Life 16%
• Social Adaptation 16%
• Thalassemia 100%
• Thalassemia Major 66%

Pharmacology, Toxicology and Pharmaceutical Science

• Anemia 33%
• Bone Disease 16%
• Chelating Agent 16%
• Chelation Therapy 16%
• Chronic Liver Disease 16%
• Deferoxamine 16%
• Delayed Puberty 16%
• Endocrine Disease 16%
• Folic Acid Deficiency 16%
• Growth Disorder 100%
• Growth Retardation 33%
• Hemosiderosis 16%
• Hypogonadism 16%
• Hypothyroidism 16%
• Hypoxia 33%
• Iron Poisoning 16%
• Life Expectancy 16%
• Nutritional Deficiency 16%
• Thalassemia 100%
• Thalassemia Major 66%